As a full-service CRO solely dedicated to biotech companies and small- to mid-sized pharma, we provide a truly unique solution.
Expertise in nearly 40 psychiatric and neurological disorders, and clinically trained neuroscience teams led by scientists and clinicians with extensive neuroscience experience.
PPD's Phase I Clinic conducts clinical studies to determine how new medicines act in the bodies of healthy volunteers.
Get information about PPD posted on industry websites and publications.
PPD Chairman and CEO Recognized for Exceptional Business Leadership
19 Sept. 2017
PPD announced that Susan Atkinson, Ph.D., senior vice president of global biometrics for PPD, has been named to the 2017 PharmaVOICE 100 list of the most inspiring people in the life sciences industry.
10 Aug. 2017
PPD announced it has appointed Christopher C. Fikry, M.D., as executive vice president of PPD® Laboratories.
27 Jun. 2017
PPD announced industry accolades earned by PPD clinical research associates (CRAs), recognizing their expertise in the endeavor of developing life-changing medicines.
08 Jun. 2017
PPD announced it has been recognized for excellence in clinical research by pharmaceutical and biotechnology executives surveyed for Life Science Leader magazine’s 2017 CRO Leadership Awards.
25 May 2017
Acurian Inc., the leading full-service provider of global patient enrollment and retention solutions and a subsidiary of PPD, announced that Tom Privette, Ph.D., has joined the company as vice president and head of global business development.
23 May 2017
PPD has expanded its vaccine sciences lab in Richmond, Virginia, enhancing its ability to provide industry-leading capabilities to meet biopharmaceutical clients’ growing research needs.
18 May 2017
Acurian Inc., the leading full-service provider of global patient enrollment and retention solutions and a subsidiary of PPD, has launched a new consulting offering to aid pharmaceutical sponsors in advance strategic planning for clinical trials enrollment.
17 May 2017
PPD announced it recently has added two new leaders in product development, strengthening the global contract research organization’s therapeutic expertise and ability to aid biopharmaceutical clients in delivering life-changing therapies to patients.
11 May 2017
PPD announced the creation of a dedicated unit combining its medical affairs research operations (MARO) team and Evidera, the provider of evidence-based solutions to demonstrate the real-world effectiveness, safety and value of biopharmaceutical and biotechnology products.
08 May 2017
Senior Manager, Corporate CommunicationsPPD
Tel: +1 919 456 4425
Corporate Communications ManagerPPD
Tel: +1 910 558 6096
We want to hear from you
Register in PPD's Database
© 2017 Pharmaceutical Product Development, LLC. All rights reserved.